FSLLRY-NH2 (TFA)

• Description:

  FSLLRY-NH2 TFA is a protease-activated receptor 2 (PAR2) inhibitor[1].

• UNSPSC:

  12352209

• Target:

  Protease Activated Receptor (PAR)

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/fsllry-nh2-tfa.html

• Purity:

  99.74

• Solubility:

  DMSO : 100 mg/mL (ultrasonic) |H2O : 1.43 mg/mL (ultrasonic)

• Smiles:

  OC1=CC=C(C=C1)C[C@@H](C(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](CC2=CC=CC=C2)N)=O)=O)=O)=O)=O.O=C(O)C(F)(F)F

• Molecular Formula:

  C41H61F3N10O10

• Molecular Weight:

  910.98

• References & Citations:

  [1]Umut Ocak, et al. FSLLRY-NH2 Improves Neurological Outcome After Cardiac Arrest in Rats. Turk Neurosurg. 2020;30 (2) :244-251.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• Isoform:

  PAR2

• Citation 01:

  BMC Musculoskelet Disord. 2022 May 30;23 (1) :514.|Biomolecules. 2025 Feb 1;15 (2) :208.|Brain Behav Immun. 2024 Jun 12:120:403-412.|Cell Signal. 2024 Aug 20:111355.|J Immunother Cancer. 2025 Jul 13;13 (7) :e010898.|Res Sq. 2024 Sep 04.